Podcast Summary
A Time of Sorrow: The Mysterious Fever of 1759: A mysterious fever swept through Bethabara in 1759, causing intense pain, delirium, and red splotches. It took the lives of several community members, including the narrator's husband, leaving deep emotional scars.
The account from 1759 describes a time of great sorrow and loss for the community of Bethabara due to a mysterious fever that took the lives of several members, including Martin, the narrator's husband. The fever symptoms included intense pain, delirium, and red splotches on the body. The fever persisted until late in the fall and seemed to be prevalent in many parts of North Carolina and Virginia. While it's debated whether this was an instance of Rocky Mountain spotted fever, the account certainly suggests some similarities. The community was deeply affected by the illness, with loved ones dying suddenly and unexpectedly. The narrator's description of holding her husband's hand and comforting him during his final moments highlights the emotional toll of the disease. The account serves as a poignant reminder of the impact of infectious diseases on communities and families.
Exploring the science behind Rocky Mountain Spotted Fever's causative organism, Rickettsia rickettsiae: Rickettsia rickettsiae is a fastidious, pleomorphic, gram-negative bacterium that causes Rocky Mountain Spotted Fever, a tick-borne disease. Humans are considered dead-end hosts, and common tick vectors include the American dog tick and Rocky Mountain wood tick.
The seemingly dull and technical description of a fastidious, small, pleomorphic, gram-negative Coxiella, Rickettsia rickettsiae, turns out to be the cause of the intriguing disease, Rocky Mountain Spotted Fever. Erin and I were excited about this episode due to personal connections and the promise of an engaging scientific story. The term "fastidious" refers to the organism's difficulty to grow in lab conditions due to its intracellular lifestyle. "Pleomorphic" means the organisms don't all look the same when viewed under a microscope. Rickettsia rickettsiae is a bacterium that causes Rocky Mountain Spotted Fever, a tick-borne disease primarily found in the New World, including North America, Central America, and South America. Humans are considered dead-end hosts, as we're not part of the normal life cycle of this pathogen. The most common ticks that transmit this disease are the American dog tick (Dermacentor variabilis) and the Rocky Mountain wood tick (Dermacentor andersonii). This episode promises an exciting exploration of the science behind this tiny but impactful organism and the disease it causes.
Ticks transmit Lyme disease through bites: Ticks become infected by feeding on hosts carrying Lyme disease bacteria, then transmit it to humans during a bite. Older tick species are more likely to infect humans.
Lyme disease is transmitted to humans when an infected tick bites and remains attached for a significant period of time, allowing the bacteria to become virulent and enter the skin. Ticks become infected by feeding on infected hosts and retaining the bacteria in their salivary glands, which can then be transmitted to the next host. The trend is that older tick species are more likely to infect humans, possibly due to behavioral preferences and the increased likelihood of acquiring the pathogen through multiple blood meals. However, transovarial transmission of the bacteria that causes Lyme disease is rare and can negatively impact the tick's reproductive output.
Transmission of Rocky Mountain Spotted Fever: Rocky Mountain Spotted Fever can spread to ticks and insects via horizontal transmission, transovarial transmission, and co-feeding. Symptoms include fever, malaise, body aches, severe headache, and a rash starting on wrists and ankles, which can later become raised and develop petechiae.
Rocky Mountain Spotted Fever (RMSF) can be transmitted to uninfected ticks or insects through various means, including horizontal transmission from an infected animal, transovarial transmission from an infected mother to offspring, and co-feeding, where two bugs feed on each other. The symptoms of RMSF typically begin with a fever, malaise, body aches, and a severe headache. Early symptoms can be mistaken for a viral syndrome. Within two weeks of infection, a rash appears, starting on the wrists and ankles and spreading up the arms and legs, as well as to the palms and soles. The rash is initially non-itchy and non-painful but can later become raised and develop petechiae, indicating potential clotting issues. It's essential to understand the transmission dynamics and symptoms of RMSF to prevent and treat it effectively.
Lyme Disease: A Leaky Pipeline Effect in the Body: Lyme disease is a potentially fatal tick-borne illness causing damage to vascular endothelium cells, leading to increased blood vessel permeability and a leaky pipeline effect, triggering an inflammatory response with a historical fatality rate of up to 85%.
Lyme disease, which starts with a rash, is a highly fatal tick-borne illness if left untreated. The bacteria, Rickettsia rickettsiae, invade and replicate in the vascular endothelium cells, causing damage that results in increased permeability of the blood vessel membranes. This leads to the leakage of fluid and proteins, creating a "leaky pipeline" effect. The damage also triggers an inflammatory response, leading to a cascading positive feedback loop. Historically, the fatality rate of Lyme disease was around 25%, with a range from 20% to 85%, making it a significant health concern.
Understanding Rocky Mountain Spotted Fever's Impact on the Body: Rare but fatal disease, caused by bacterial infection, leads to inflammation, vasodilation, increased vascular permeability, edema, hypovolemia, and potential organ failure or shock. Misdiagnosis, particularly in black individuals, contributes to high mortality rates, making proper education and representation essential.
Rocky Mountain Spotted Fever is a serious disease caused by bacterial infection, leading to inflammation and vasodilation. This results in increased vascular permeability, edema, and hypovolemia, potentially causing organ failure and shock. Mortality rates, even with treatment, remain high due to delays in diagnosis and misdiagnosis, particularly in black individuals whose rashes are often overlooked due to lack of representation in medical resources. The disease is under-recognized despite increasing risk with landscape and climate change. It's a rare but fatal condition that requires clinical diagnosis based on symptoms and rash appearance, making proper education and representation crucial to prevent unnecessary deaths.
History of Rocky Mountain Spotted Fever: Misunderstood Disease: Rocky Mountain Spotted Fever, despite its misleading name, is a disease prevalent in various parts of the world, including the Eastern seaboard, South America, and Central America, and its history is marked by confusion and ongoing research.
The history of Rocky Mountain Spotted Fever (RMSF) is marked by confusion due to the disease's location-specific names and its occurrence in various parts of the world. The name "Rocky Mountain Spotted Fever" is misleading as the disease is not exclusive to the Rocky Mountains or the Western States, but also prevalent in the Eastern seaboard, South America, and Central America. The history of RMSF research is filled with drama and romance, as depicted in movies like "Greenlight" and "Driftwood." The disease's story began in the late 1800s when a mysterious illness was reported in Montana's Bitterroot Valley. The valley, known for its ample resources and increasing white settlers, saw the removal of the Salish tribe, who were the original inhabitants of the land. The firsthand account of the disease dates back to 1759, but it wasn't until the late 1800s that the disease gained significant attention. Despite the confusion surrounding the disease's name and location, researchers have continued to investigate and make progress in understanding and treating RMSF.
The Emergence of Rocky Mountain Spotted Fever in the Bitterroot Valley: The clear cutting of land led to an increase in scrub habitat, attracting mice and ticks, causing the spread of Rocky Mountain Spotted Fever with a high mortality rate. Humans could not prevent it through elimination of ticks or their hosts.
The clear cutting of land in the Bitterroot Valley during the late 1800s led to the emergence and spread of Rocky Mountain Spotted Fever. The removal of the Salish people and the creation of orchards and farms resulted in an increase in scrub habitat, which attracted mice and other small mammals, making ideal hosts for ticks. The first recorded case of the disease occurred in Montana in 1873, and its spread to other states including Colorado, Oregon, Idaho, and Wyoming raised alarm. A bacteriologist named Earl Strain suggested a connection between the disease and a tick bite, and researchers William and Chowning confirmed this hypothesis through autopsies, epidemiological surveys, and lab studies. Between 1895 and 1902, there were 88 cases in the Bitterroot Valley with a 72.7 mortality rate. The disease was not contagious from person to person, and it was not caused by melted snow water. Instead, it was caused by a protozoan transmitted by wood ticks, with ground squirrels as the disease reservoirs. The only practical steps to prevent the disease were to eliminate ticks or their hosts, which was not a viable solution. This unfortunate cycle highlights the consequences of human actions on the environment and public health.
Early attempts to control ticks and their diseases in Bitterroot Valley: Researchers like Charles Wardell Styles and Howard Taylor Ricketts debunked misconceptions about tick transmission of diseases through groundbreaking research in the early 1900s.
The residents of Bitterroot Valley took drastic measures to control ticks and the diseases they carried in the early 1900s. They burned vegetation, set out poison grain, and even introduced sheep to eat the grass they believed was the tick's habitat. However, their efforts were largely unsuccessful, and the misconceptions about the role of ticks in the transmission of diseases continued. Charles Wardell Styles, a researcher known for his work on hookworm, challenged the hypothesis that ticks transmitted protozoa. His dismissive attitude towards the hypothesis drew attention to the issue, leading other researchers like Howard Taylor Ricketts to take up the cause. Ricketts, with the help of Wilson and Chowning, conducted groundbreaking research in a tent laboratory in Montana, ultimately proving that ticks were indeed the vectors for Rocky Mountain Spotted Fever. Despite initial setbacks and lack of collaboration, their work paved the way for a better understanding of tick-borne diseases.
The Discovery of Rickettsia rickettsii - The Causative Agent of Rocky Mountain Spotted Fever: Perseverance, collaboration, and scientific discoveries led to the identification of Rickettsia rickettsii, the causative agent of Rocky Mountain Spotted Fever, revolutionizing our understanding of tick-borne diseases.
The discovery of the causative agent of Rocky Mountain Spotted Fever involved years of persistent research, collaboration, and determination despite numerous challenges. Ricketts and King discovered that ticks could transmit the disease, but they missed the opportunity to study the causative agent during tick season due to lack of available ticks. In 1909, Ricketts identified the teeny tiny bacillus, Rickettsia rickettsii, as the causative agent, but the funding for his research was suspended. Despite this setback, Ricketts continued his research in Mexico to study typhus, but unfortunately, he contracted the disease and died before he could complete his work. The discovery of the causative agent of Rocky Mountain Spotted Fever revolutionized the understanding of tick-borne diseases and paved the way for further research in this area. The story highlights the importance of perseverance, collaboration, and the significant impact of scientific discoveries on public health.
Physician-Entomologist Rivalry Hindered Rocky Mountain Spotted Fever Research: Egos and disagreements between physicians and entomologists over research priorities and methods hindered progress in controlling Rocky Mountain spotted fever during the early 1900s, resulting in a fragmented research landscape and limited progress.
The lack of collaboration between physicians and entomologists in Rocky Mountain spotted fever research during the early 1900s hindered progress and resulted in missed opportunities. This was evident in the case of the rivalry between McClintock, a physician, and Cooley, an entomologist, in Montana. Their egos and disagreements over research priorities and methods led to a divisive and ineffective approach to controlling the disease. Despite their different expertise, a combined effort was necessary to fully understand the ecology of the tick vector and the characteristics of the disease. Unfortunately, this collaboration never truly materialized due to funding and territorial disputes, resulting in a fragmented research landscape and limited progress in controlling Rocky Mountain spotted fever.
Discoveries in the 1920s led to a better understanding of Rocky Mountain Spotted Fever but didn't immediately decrease its impact: Though discoveries in the 1920s advanced our knowledge of Rocky Mountain Spotted Fever, the lack of a successful vaccine and high mortality rate kept it a major health concern, leading to increased funding and collaboration between entomologists and physicians to find a solution.
The discovery of the causative agent of Rocky Mountain Spotted Fever in the 1920s was a significant scientific achievement, but it did not immediately lead to a decrease in the incidence and mortality of the disease. Researchers, including Wolbach and Ricketts, made important discoveries about intracellular microbes, leading to the acceptance of a new type of microbial life. However, the lack of a successful vaccine and the high mortality rate kept the disease a major concern. Panic ensued, and funds were finally allocated to establish a laboratory to focus on finding a solution. The collaboration between entomologist Ralph Parker and physician Roscoe Spencer led to advancements in both ecological studies and vaccine development. Despite these efforts, the disease continued to pose a significant threat, with high mortality rates and economic impacts.
The Challenging History of Rocky Mountain Spotted Fever Vaccine Development: Scientists faced numerous setbacks, hazardous working conditions, and even fatalities while developing a vaccine for Rocky Mountain Spotted Fever during the early 20th century. Despite these challenges, they persevered and eventually created a successful vaccine, reducing fatality rates.
The development of a vaccine for Rocky Mountain Spotted Fever during the early 20th century was a risky and challenging process, marked by numerous setbacks and tragedies. Despite the doubts surrounding Noguchi's vaccine, researchers like Spencer continued their work, only to face new challenges with the emergence of tularemia. The working conditions at the Schoolhouse Labs were hazardous, with researchers and students falling ill and even dying from the diseases they were studying. However, the community rallied behind the researchers when they began testing a new vaccine in 1925, with volunteers eager to protect themselves from the deadly diseases. Retrospective studies showed that the vaccine was effective in reducing fatality rates, but concerns about the hazardous working conditions led to the construction of new, more secure facilities. Overall, the history of Rocky Mountain Spotted Fever research is a testament to the determination and bravery of scientists in the face of dangerous and uncertain circumstances.
Discovering Rocky Mountain Spotted Fever and the Establishment of the Rocky Mountain Laboratory: During the Great Depression, the discovery of Rocky Mountain Spotted Fever and the establishment of the Rocky Mountain Laboratory led to the development of a potential vaccine, despite funding challenges. An accidental discovery in 1936 revolutionized rickettsiae research, expanding the lab's role and leading to new methods of vaccine production.
The discovery of Rocky Mountain Spotted Fever and the establishment of the Rocky Mountain Laboratory during the Great Depression were crucial moments in medical history. The availability of a potential vaccine allayed fears, but its production was a labor-intensive process. Funding for research was threatened, but a researcher's moral stance led to its preservation. An accidental discovery in 1936 at the lab revolutionized rickettsiae research, leading to new methods of vaccine production and expanding the lab's role beyond spotted fever. This history holds significance not only for Rocky Mountain Spotted Fever research but also for understanding the impact of government funding on scientific advancements and the potential consequences of discontinuing research.
Role of Rocky Mountain Lab in Producing Vaccines During WW2: Rocky Mountain Lab played a crucial role in producing vaccines for typhus and yellow fever during WW2, turning it into a national vaccine factory. Discovery of antibiotics led to decline in preventative research, but budget cuts eliminated medical entomology research program, leading to intriguing discovery of tick interference phenomenon.
During World War 2, the Rocky Mountain Laboratory played a crucial role in producing vaccines for typhus and yellow fever, turning it into a national vaccine factory. This was particularly important as these diseases were a major concern for US soldiers stationed in endemic regions. The discovery of antibiotics in the 1940s and 1950s led to a decline in the urgency for preventative research on diseases like spotted fever. However, budget cuts in the 1970s eliminated the medical entomology research program at Rocky Mountain Lab, and the tick collection was shipped to the Smithsonian. One intriguing discovery made during this time was the interference phenomenon, where non-pathogenic rickettsia in ticks prevented the pathogenic rickettsia that causes spotted fever from colonizing the ticks. This discovery helped explain why the east side of the Bitterroot River remained protected from the west side, where spotted fever was more prevalent. Overall, the history of Rocky Mountain Laboratory showcases the importance of scientific research in preventing and understanding the spread of infectious diseases.
No vaccine for Rocky Mountain Spotted Fever despite a century of research: Despite over a century of research, no vaccine exists for Rocky Mountain Spotted Fever. The increasing number of reported cases in the US and the difficulty in differentiating it from other diseases make accurate reporting and prevention crucial.
Despite over a century of research, there is still no vaccine for Rocky Mountain Spotted Fever (RMSF), a tick-borne disease causing severe flu-like symptoms. The lack of funding and interest from both the research and pharmaceutical industries, as well as the difficulty in developing vaccines for rickettsiae, are major obstacles. The number of reported cases in the United States has been increasing steadily since the year 2000, with over 6,000 cases reported in 2017, up from under 500 in the year 2000. The difficulty in differentiating RMSF from other rickettsial diseases makes accurate reporting challenging. While research continues, the focus is on understanding the disease better and finding ways to prevent tick bites.
Rise in reported RMSF cases and improved survival rates: Improved recognition and reporting, as well as effective treatment, have led to a decrease in RMSF case fatality rates in the US, while some regions in Mexico face increasing case fatalities and underreporting of cases, particularly in children.
The increase in reported cases of Rocky Mountain Spotted Fever (RMSF) and other rickettsiosis in the US over the past few decades could be due to a combination of improved recognition and reporting, as well as an actual increase in infections. However, the drastic decrease in case fatality rates in the US, from around 5% to as low as 0.5%, is a cause for celebration. In contrast, in some regions of Mexico, the case fatality rate has been increasing, suggesting a need for better diagnostic tools and access to treatment. Additionally, a large proportion of cases, particularly in children, may go unreported due to the hesitance to use tetracyclines for treatment in kids, despite it being an effective and safe option for RMSF. Overall, less than 1% of spotted fever group rickettsiosis cases in the US are lab confirmed, highlighting the importance of awareness and reporting of tick bites, fever, rash, or headache symptoms. Brett's story serves as a reminder of the importance of understanding the ecology of tick-borne diseases and the need for awareness and prompt treatment.
A seemingly harmless ailment leads to a serious diagnosis: Promptly seek medical attention for unusual symptoms, especially when there's a possibility of a tick-borne illness, and be cautious about disposing of potential health hazards like ticks.
A seemingly harmless ailment, which was initially thought to be a simple fever, turned out to be a serious case of Rocky Mountain Spotted Fever. The brother, Brett, had ignored the initial symptoms and dismissed them as a common illness. However, the presence of an unusual rash and the discovery of a tick that had been flushed down the toilet led to a proper diagnosis. This incident underscores the importance of seeking medical attention promptly when experiencing unusual symptoms, especially when there is a possibility of a tick-borne illness. It also serves as a reminder to be cautious about disposing of potential health hazards like ticks and to be aware of the signs and symptoms of tick-borne diseases.
Overcoming Fear to Explore New Topics: Despite initial apprehension, it's important to tackle new topics, even if related to academic backgrounds. Leverage various sources and don't forget to wash hands.
Fear should not hold us back from exploring new topics, even if they are related to our academic backgrounds. During the production of our podcast episode about Rocky Mountain Spotted Fever, the speaker initially felt apprehensive as the topic was close to their PhD research. However, they soon realized that it was a separate topic with its unique aspects. The speaker relied on various sources for the episode, including the book "Rocky Mountain Spotted Fever: History of a 20th Century Disease" by Victoria Hardin, as well as several papers on the biology and epidemiology of the disease. All sources will be made available on the podcast's website for listeners. The speaker also expressed gratitude to Bloodmobile for providing the music for the podcast and encouraged everyone to listen to the episode. They ended the podcast with a reminder to wash hands and a hope that the audience enjoyed the episode as much as they did while producing it.
First, the editors speak with first author Michael Harhay, PhD (pictured left) and senior author Edward Cantu, MD (pictured right), about their study from the University of Pennsylvania entitled “
Next, we hear from Anne Dipchand, MD (pictured), Professor of Pediatrics and Pediatric Cardiologist at the Hospital for Sick Children in Toronto, Canada, who is senior author on the study, “
First, the editors speak with Paulino Alvarez, MD, from the Cleveland Clinic, about his paper entitled “
Next, a study on the lung transplant allocation system with co-authors Erika Lease, MD (pictured left, from the JHLT Digital Media Editorial team!) and Maryam Valapour, MD, MPP (pictured right). Drs. Lease and Valapour share details about their multidisciplinary backgrounds, and how those experiences have influenced their research careers. Then, they share details about their study: “